The presence of multicomponent dense nonaqueous phase liquid (DNAPL) mixtures in porous media can significantly limit the effectiveness of groundwater remediation. A series of column transport and flushing experiments were conducted to quantify the impact of various enhanced flushing agents on dissolution and removal of a multicomponent DNAPL source within a macroscopically homogeneous porous medium. The columns were established with NAPL saturations consisting of an equal mole mixture of cis-1,2-dichloroethene, trichloroethene, and tetrachloroethene. The solubilization agents used included two complexing sugars - hydroxypropyl-β-cyclodextrin (HPCD and methyl-β-cyclodextrin (MCD); a surfactant - sodium dodecyl sulfate (SDS); and a cosolvent - ethanol (EtOH). The chemical flushing agents greatly reduced the time needed to remove each DNAPL component, compared to flushing with water alone. Initial DNAPL-component elution concentrations were successfully predicted using Raoult's Law for MCD, HPCD, and water flushing, indicating that ideal dissolution was initiated by the lower-power enhanced-solubilization agents. EtOH was most efficient at removing the contaminants in terms of normalized mass recovery but least efficient based on a mass-ratio and mole-ratio of contaminant to reagent analysis. SDS was most efficient for contaminant removal when analyzed based on mass-contaminant to mass-reagent recovered and MCD was most effective based on a moles-contaminant to moles-reagent recovered efficiency evaluation. However, in terms of mass flux reduction analysis (i.e. removal metric), SDS was least efficient for contaminant removal compared to all other enhanced-flushing agents tested, especially during the initial stages of DNAPL removal. Results from this study indicate that ideal dissolution was initiated during enhanced-solubilization and that several criteria should be used to evaluate the removal effectiveness of flushing agents for multi-component NAPL systems.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jconhyd.2022.103967 | DOI Listing |
Background: To report clinical outcomes from a single-center cohort undergoing PAUL® Glaucoma Implant (PGI) surgery for secondary glaucoma after vitreoretinal surgery (VR).
Methods: Retrospective review of patients undergoing PGI surgery at the University Eye Hospital Bonn, Germany, from 04/2021 to 05/2023.
Results: 33 eyes of 33 patients were included.
Medicine (Baltimore)
November 2024
Department of Clinical Pharmacy, Shanghai General Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Background: Patients with hematological malignancies are at high-risk of Clostridium difficile infection (CDI). Oral vancomycin is a first-line treatment for CDI. Vancomycin has been widely reported to induce flushing syndrome (also known as Red man syndrome), a well-known hypersensitivity reaction mostly occurs after intravenous administration.
View Article and Find Full Text PDFMedicine (Baltimore)
November 2024
Department of Pharmacy, Baiyin Central Hospital, Baiyin, Gansu, China.
Rationale: It is imperative to be cautious about the potential systemic allergic reaction caused by the combined use of Qing Kailing Injection (QKI) and clindamycin as it may be life-threatening.
Patient Concerns: A 48-year-old female with a history of hypertension was admitted to a private hospital with a fever and cough. She was diagnosed with lung infection and received QKI infusion, followed by clindamycin infusion.
Am Surg
January 2025
Department of Surgery, Division of Acute Care Surgery and Surgical Critical Care, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Fungal growth is common in intraoperative cultures of patients with perforated peptic ulcer (PPU) leading to the common use of empiric antifungal therapy, with current evidence not clearly supporting this practice. The goal of this updated systematic review and meta-analysis was to synthesize the effect of empiric antifungals in patients with PPU. Eligible studies were identified through a comprehensive literature search in the MEDLINE (PubMed) and EMBASE databases, following the PRISMA 2020 statement.
View Article and Find Full Text PDFTurk J Med Sci
December 2024
Division of Clinical Immunology and Allergy, Department of Chest Diseases, Faculty of Medicine, Ankara University, Ankara, Turkiye.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!